TN2010000305A1 - Pyrrolopyrimidines and pyrrolopyridines - Google Patents
Pyrrolopyrimidines and pyrrolopyridinesInfo
- Publication number
- TN2010000305A1 TN2010000305A1 TN2010000305A TN2010000305A TN2010000305A1 TN 2010000305 A1 TN2010000305 A1 TN 2010000305A1 TN 2010000305 A TN2010000305 A TN 2010000305A TN 2010000305 A TN2010000305 A TN 2010000305A TN 2010000305 A1 TN2010000305 A1 TN 2010000305A1
- Authority
- TN
- Tunisia
- Prior art keywords
- compounds
- pyrrolopyridines
- pyrrolopyrimidines
- alk
- meanings
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Biotechnology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08150182 | 2008-01-11 | ||
PCT/EP2009/050225 WO2009087225A2 (fr) | 2008-01-11 | 2009-01-09 | Pyrrolopyrimidines et pyrrolopyridines |
Publications (1)
Publication Number | Publication Date |
---|---|
TN2010000305A1 true TN2010000305A1 (en) | 2011-11-11 |
Family
ID=39445770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TN2010000305A TN2010000305A1 (en) | 2008-01-11 | 2010-06-30 | Pyrrolopyrimidines and pyrrolopyridines |
Country Status (22)
Country | Link |
---|---|
US (1) | US8314112B2 (fr) |
EP (1) | EP2242756A2 (fr) |
JP (1) | JP5643110B2 (fr) |
KR (1) | KR20100116606A (fr) |
CN (1) | CN101970435B (fr) |
AR (1) | AR070127A1 (fr) |
AU (1) | AU2009203694B2 (fr) |
BR (1) | BRPI0907231A2 (fr) |
CA (1) | CA2711845A1 (fr) |
CL (1) | CL2009000028A1 (fr) |
CO (1) | CO6331340A2 (fr) |
CR (1) | CR11554A (fr) |
EA (1) | EA201001126A1 (fr) |
EC (1) | ECSP10010335A (fr) |
IL (1) | IL206819A0 (fr) |
MA (1) | MA31952B1 (fr) |
MX (1) | MX2010007605A (fr) |
PE (1) | PE20091306A1 (fr) |
TN (1) | TN2010000305A1 (fr) |
TW (1) | TW200934781A (fr) |
WO (1) | WO2009087225A2 (fr) |
ZA (1) | ZA201004602B (fr) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2007003444A1 (es) * | 2006-11-30 | 2008-06-27 | Genentech Inc | Compuestos derivados de pirrolo[3,2-c]piridina; composicion farmaceutica; y uso en el tratamiento de un trastorno hiperproliferativo o una enfermedad inflamatoria. |
MX2010006457A (es) | 2007-12-19 | 2010-07-05 | Amgen Inc | Compuestos fusionados de piridina, pirimidina y triazina como inhibidores de ciclo celular. |
ATE531372T1 (de) | 2008-04-07 | 2011-11-15 | Amgen Inc | Gem-disubstituierte und spirocyclische aminopyridine/pyrimidine als zellcyclus- inhibitoren |
SI2300013T1 (en) | 2008-05-21 | 2018-03-30 | Adriad Pharmacaceuticals, Inc. | Phosphorus derivatives as kinase inhibitors |
US9273077B2 (en) | 2008-05-21 | 2016-03-01 | Ariad Pharmaceuticals, Inc. | Phosphorus derivatives as kinase inhibitors |
CA2676946A1 (fr) * | 2009-08-28 | 2011-02-28 | Lucie Peduto | Inhibiteurs de l'enzyme adam12 et leur utilisation contre la fibrose induite par l'inflammation |
WO2011032050A2 (fr) * | 2009-09-11 | 2011-03-17 | Trius Therapeutics, Inc. | Inhibiteurs de gyrase |
JP5675850B2 (ja) | 2010-02-05 | 2015-02-25 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | ヘタリール−[1,8]ナフチリジン誘導体 |
AU2011217561B2 (en) | 2010-02-22 | 2016-04-21 | Merck Patent Gmbh | Hetarylaminonaphthyridines |
EP2539338A1 (fr) * | 2010-02-24 | 2013-01-02 | Syngenta Participations AG | Nouveaux microbicides |
EP2589592B1 (fr) | 2010-06-30 | 2018-08-22 | FUJIFILM Corporation | Nouveaux dérivés de nicotinamide et leurs sels |
DK2624696T3 (en) | 2010-10-06 | 2017-03-13 | Glaxosmithkline Llc Corp Service Company | BENZIMIDAZOLD DERIVATIVES AS PI3-KINASE INHIBITORS |
EP2688887B1 (fr) | 2011-03-23 | 2015-05-13 | Amgen Inc. | Doubles inhibiteurs tricycliques fusionnés de cdk 4/6 et de flt3 |
EA201391626A1 (ru) | 2011-05-04 | 2014-03-31 | Ариад Фармасьютикалз, Инк. | Соединения для ингибирования клеточной пролиферации в egfr-стимулированных типах рака |
CN103635189B (zh) | 2011-07-01 | 2016-05-04 | 诺华股份有限公司 | 用于治疗癌症的含有cdk4/6抑制剂和pi3k抑制剂的联合治疗 |
EP2573086A1 (fr) * | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | Monohydrate de mesylate acétamide N-[5-(Aminosulfonyl)-4-méthyl-1,3-thiazol-2-yl]-N-méthyl-2-[4-(2-pyridinyl)phényl] |
EP2573085A1 (fr) | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | Monohydrate de mesylate acétamide N-[5-(aminosulfonyl)-4méthyl-1,3-thiazol-2-yl]-N-méthyl-2-[4-(2-pyridinyl)phényl] disposant d'une gamme de distribution de taille de particules spécifiques et portée de surface spécifique |
JP6469567B2 (ja) | 2012-05-05 | 2019-02-13 | アリアド・ファーマシューティカルズ・インコーポレイテッド | Egfr発動性がんの細胞増殖阻害用化合物 |
JO3407B1 (ar) | 2012-05-31 | 2019-10-20 | Eisai R&D Man Co Ltd | مركبات رباعي هيدرو بيرازولو بيريميدين |
CA2873723A1 (fr) * | 2012-06-07 | 2013-12-12 | F. Hoffmann-La Roche Ag | Inhibiteurs pyrrolopyrimidone et pyrrolopyridone de la tankyrase |
US9353107B2 (en) * | 2012-07-03 | 2016-05-31 | Aurigene Discovery Technologies Limited | 3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitors |
EP2970311A4 (fr) | 2013-03-14 | 2016-11-23 | Brigham & Womens Hospital | Inhibiteurs de bmp et leurs procédés d'utilisation |
US9611283B1 (en) | 2013-04-10 | 2017-04-04 | Ariad Pharmaceuticals, Inc. | Methods for inhibiting cell proliferation in ALK-driven cancers |
WO2014195333A1 (fr) | 2013-06-04 | 2014-12-11 | Bayer Pharma Aktiengesellschaft | Imidazo[1,2-a]pyridines à substitution 3-aryle et leur utilisation |
CA2939793A1 (fr) | 2014-02-19 | 2015-08-27 | Bayer Pharma Aktiengesellschaft | 3-(pyrimidin-2-yl)imidazo[1,2-a]pyridines |
EP3122355A4 (fr) * | 2014-03-26 | 2017-08-09 | The Brigham and Women's Hospital, Inc. | Compositions et procédés d'inhibition de la bmp |
TW201613916A (en) | 2014-06-03 | 2016-04-16 | Gilead Sciences Inc | TANK-binding kinase inhibitor compounds |
US10513521B2 (en) | 2014-07-15 | 2019-12-24 | The Brigham And Women's Hospital, Inc. | Compositions and methods for inhibiting BMP |
SG11201701724VA (en) | 2014-09-26 | 2017-04-27 | Gilead Sciences Inc | Aminotriazine derivatives useful as tank-binding kinase inhibitor compounds |
CN107001361A (zh) | 2014-12-02 | 2017-08-01 | 拜耳医药股份有限公司 | 杂芳基取代的咪唑并[1,2‑a]吡啶及其用途 |
WO2016172496A1 (fr) | 2015-04-23 | 2016-10-27 | Constellation Pharmaceuticals, Inc. | Inhibiteurs de lsd1 et leurs utilisations |
WO2016183071A1 (fr) | 2015-05-11 | 2016-11-17 | Incyte Corporation | Composés hétéro-tricycliques substitués et utilisation de ces composés pour le traitement du cancer |
WO2017027717A1 (fr) | 2015-08-12 | 2017-02-16 | Incyte Corporation | Composés de pyrimidine fusionnés bicycliques utilisés en tant qu'inhibiteurs de tam |
US10053465B2 (en) | 2015-08-26 | 2018-08-21 | Incyte Corporation | Pyrrolopyrimidine derivatives as TAM inhibitors |
FR3041640B1 (fr) | 2015-09-30 | 2019-05-17 | Les Laboratoires Servier | NOUVEAUX DERIVES DE PYRROLO[2,3-d]PYRIMIDINE, LEUR PROCEDE DE PREPRATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT |
CA3006772A1 (fr) | 2015-12-17 | 2017-06-22 | Gilead Sciences, Inc. | Composes inhibiteurs de kinases se liant a tank |
JP7114076B2 (ja) | 2015-12-22 | 2022-08-08 | シャイ・セラピューティクス・エルエルシー | がん及び炎症性疾患の処置のための化合物 |
SI3436461T1 (sl) | 2016-03-28 | 2024-03-29 | Incyte Corporation | Pirolotriazinske spojine kot tam-inhibitorji |
MX2018012664A (es) | 2016-04-15 | 2019-03-07 | Blueprint Medicines Corp | Inhibidores de quinasa tipo receptor de activina. |
HRP20231369T1 (hr) | 2016-10-26 | 2024-02-16 | Constellation Pharmaceuticals, Inc. | Inhibitori lsd1 i njihova medicinska upotreba |
MX2019014875A (es) | 2017-06-21 | 2021-01-29 | SHY Therapeutics LLC | Compuestos que interaccionan con la superfamilia ras para el tratamiento de cancer, enfermedades inflamatorias, rasopatias y enfermedad fibrotica. |
CN109384782A (zh) * | 2017-08-04 | 2019-02-26 | 厦门大学 | 取代五元并六元杂环类化合物、其制备方法、药物组合及其用途 |
RS62872B1 (sr) | 2017-09-27 | 2022-02-28 | Incyte Corp | Soli derivata pirrolotriazina korisne kao tam inhibitori |
WO2019079649A1 (fr) * | 2017-10-18 | 2019-04-25 | Blueprint Medicines Corporation | Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de la kinase apparentée au récepteur de l'activine |
RU2020124116A (ru) | 2017-12-22 | 2022-01-25 | Хиберселл, Инк. | Производные арил-бипиридинамина в качестве ингибиторов фосфатидилинозитолфосфаткиназы |
WO2019180269A1 (fr) * | 2018-03-23 | 2019-09-26 | Cytoo | Inhibiteurs d'alk5 en tant qu'inducteurs d'hypertrophie musculaire squelettique |
CN117771250A (zh) | 2018-06-29 | 2024-03-29 | 因赛特公司 | Axl/mer抑制剂的制剂 |
WO2020012357A1 (fr) * | 2018-07-10 | 2020-01-16 | Integral Biosciences Pvt. Ltd. | Composés hétérocycliques et procédés d'utilisation |
CN111018858B (zh) * | 2018-10-10 | 2022-11-18 | 复旦大学 | 杂环类衍生物及其制备方法和用途 |
TWI827760B (zh) * | 2018-12-12 | 2024-01-01 | 加拿大商愛彼特生物製藥公司 | 經取代之芳基甲基脲類及雜芳基甲基脲類、其類似物及其使用方法 |
KR20200105246A (ko) * | 2019-02-28 | 2020-09-07 | 한미약품 주식회사 | 아데노신 수용체 길항제로서 신규 화합물 및 이를 포함하는 약학 조성물 |
AU2021239135B2 (en) * | 2020-03-16 | 2024-05-02 | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Substituted pyrimidine or pyridine amine derivative, composition thereof, and medical use thereof |
CN113698395B (zh) * | 2020-05-22 | 2023-12-08 | 赛诺哈勃药业(成都)有限公司 | 转化生长因子受体拮抗剂、其制备方法和应用 |
IL298760A (en) | 2020-06-05 | 2023-02-01 | Kinnate Biopharma Inc | Fibroblast growth factor receptor kinase inhibitors |
EP4182322B1 (fr) | 2020-07-15 | 2024-04-24 | Chiesi Farmaceutici S.p.A. | Dérivés de pyrido-oxazine en tant qu'inhibiteurs d'alk5 |
BR112023000588A8 (pt) | 2020-07-15 | 2023-05-09 | Chiesi Farm Spa | Derivados de piridazinil amino como inibidores de alk5 |
BR112023000592A2 (pt) | 2020-07-15 | 2023-01-31 | Chiesi Farm Spa | Derivados de pirido oxazina amino como inibidores de alk5 |
EP4267584A1 (fr) | 2020-12-23 | 2023-11-01 | Chiesi Farmaceutici S.p.A. | Dérivés de pyrido-oxazine utilisés comme inhibiteurs d'alk5 |
TW202328102A (zh) | 2021-09-21 | 2023-07-16 | 義大利商吉斯藥品公司 | 作為alk5抑制劑之嗒𠯤基胺基衍生物 |
WO2023208986A1 (fr) | 2022-04-27 | 2023-11-02 | Chiesi Farmaceutici S.P.A. | Dérivés d'imidazole en tant qu'inhibiteurs d'alk5 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL175347B1 (pl) | 1992-04-03 | 1998-12-31 | Upjohn Co | Trójpierścieniowe heterocykliczne aminy aktywne farmaceutycznie |
US6686366B1 (en) * | 1998-06-02 | 2004-02-03 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
JP2002540206A (ja) * | 1999-03-11 | 2002-11-26 | ニューロゲン コーポレイション | アリールの縮合した2,4−二置換ピリジン:nk3受容体リガンド |
US7160890B2 (en) | 1999-12-02 | 2007-01-09 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
PT1246623E (pt) | 1999-12-02 | 2006-12-29 | Osi Pharm Inc | Compostos específicos para o receptor de adenosina a1,a2a e a3 e as suas utilizações |
US6680322B2 (en) | 1999-12-02 | 2004-01-20 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptors and uses thereof |
US6680324B2 (en) | 2000-12-01 | 2004-01-20 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A1 receptors and uses thereof |
NZ525885A (en) | 2000-12-01 | 2005-01-28 | Osi Pharm Inc | Compounds specific to adenosine A1, A2A, and A3 receptor and uses as ubiquitous modulators of physiological activities |
US6673802B2 (en) | 2000-12-01 | 2004-01-06 | Osi Pharmaceuticals, Inc. | Compounds specific to adenosine A3 receptor and uses thereof |
GB0100622D0 (en) | 2001-01-10 | 2001-02-21 | Vernalis Res Ltd | Chemical compounds V111 |
WO2003048120A2 (fr) | 2001-11-30 | 2003-06-12 | Osi Pharmaceuticals, Inc. | Composes specifiques des recepteurs a1 et a3 de l'adenosine et leurs utilisations |
US20030139427A1 (en) * | 2002-08-23 | 2003-07-24 | Osi Pharmaceuticals Inc. | Bicyclic pyrimidinyl derivatives and methods of use thereof |
WO2004065392A1 (fr) * | 2003-01-24 | 2004-08-05 | Smithkline Beecham Corporation | Pyridines et pyrimidines condensees et leur utilisation en tant que ligands du recepteur alk-5 |
WO2004081009A1 (fr) * | 2003-03-12 | 2004-09-23 | Millennium Pharmaceuticals, Inc. | Derives de quinazoline utilises en tant qu'inhibiteurs de tgf-beta |
US20050205625A1 (en) * | 2004-03-16 | 2005-09-22 | House Arthur G | Container support device, system, and method |
US20060205625A1 (en) | 2005-02-18 | 2006-09-14 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
RU2409366C2 (ru) | 2005-02-18 | 2011-01-20 | Зольвай Фармасьютиклз Гмбх | Фармацевтические композиции, включающие ингибиторы nep, ингибиторы системы, продуцирующей эндогенный эндотелин, и диуретики |
US20070014956A1 (en) * | 2005-07-14 | 2007-01-18 | Mccarthy Dillon P | Adhesive tape device |
CA2634787C (fr) * | 2005-12-23 | 2014-10-21 | Smithkline Beecham Corporation | Inhibiteurs azaindoliques des kinases aurora |
-
2009
- 2009-01-08 AR ARP090100050A patent/AR070127A1/es not_active Application Discontinuation
- 2009-01-09 AU AU2009203694A patent/AU2009203694B2/en not_active Ceased
- 2009-01-09 US US12/351,438 patent/US8314112B2/en not_active Expired - Fee Related
- 2009-01-09 EA EA201001126A patent/EA201001126A1/ru unknown
- 2009-01-09 EP EP20090700871 patent/EP2242756A2/fr not_active Withdrawn
- 2009-01-09 MX MX2010007605A patent/MX2010007605A/es active IP Right Grant
- 2009-01-09 BR BRPI0907231A patent/BRPI0907231A2/pt not_active IP Right Cessation
- 2009-01-09 CN CN200980108446.3A patent/CN101970435B/zh not_active Expired - Fee Related
- 2009-01-09 KR KR1020107017744A patent/KR20100116606A/ko not_active Application Discontinuation
- 2009-01-09 CA CA2711845A patent/CA2711845A1/fr not_active Abandoned
- 2009-01-09 WO PCT/EP2009/050225 patent/WO2009087225A2/fr active Application Filing
- 2009-01-09 JP JP2010541794A patent/JP5643110B2/ja not_active Expired - Fee Related
- 2009-01-09 CL CL2009000028A patent/CL2009000028A1/es unknown
- 2009-01-09 PE PE2009000024A patent/PE20091306A1/es not_active Application Discontinuation
- 2009-01-09 TW TW098100815A patent/TW200934781A/zh unknown
-
2010
- 2010-06-30 MA MA32971A patent/MA31952B1/fr unknown
- 2010-06-30 TN TN2010000305A patent/TN2010000305A1/fr unknown
- 2010-06-30 ZA ZA2010/04602A patent/ZA201004602B/en unknown
- 2010-07-02 CR CR11554A patent/CR11554A/es not_active Application Discontinuation
- 2010-07-05 IL IL206819A patent/IL206819A0/en unknown
- 2010-07-09 EC EC2010010335A patent/ECSP10010335A/es unknown
- 2010-07-12 CO CO10084491A patent/CO6331340A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2009203694A1 (en) | 2009-07-16 |
ECSP10010335A (es) | 2010-08-31 |
EA201001126A1 (ru) | 2011-02-28 |
TW200934781A (en) | 2009-08-16 |
MA31952B1 (fr) | 2010-12-01 |
AR070127A1 (es) | 2010-03-17 |
CR11554A (es) | 2010-08-11 |
CA2711845A1 (fr) | 2009-07-16 |
US8314112B2 (en) | 2012-11-20 |
KR20100116606A (ko) | 2010-11-01 |
US20090181941A1 (en) | 2009-07-16 |
WO2009087225A3 (fr) | 2009-11-05 |
MX2010007605A (es) | 2010-08-02 |
CN101970435A (zh) | 2011-02-09 |
ZA201004602B (en) | 2011-03-30 |
BRPI0907231A2 (pt) | 2019-09-24 |
JP2011509279A (ja) | 2011-03-24 |
IL206819A0 (en) | 2010-12-30 |
PE20091306A1 (es) | 2009-09-24 |
CN101970435B (zh) | 2014-07-02 |
CL2009000028A1 (es) | 2009-07-17 |
CO6331340A2 (es) | 2011-10-20 |
WO2009087225A2 (fr) | 2009-07-16 |
JP5643110B2 (ja) | 2014-12-17 |
AU2009203694B2 (en) | 2012-04-26 |
EP2242756A2 (fr) | 2010-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2010000305A1 (en) | Pyrrolopyrimidines and pyrrolopyridines | |
ZA201000079B (en) | Organic compounds | |
TN2010000167A1 (en) | Organic compounds | |
EA201001687A1 (ru) | Производные имидазопиридина в качестве ингибиторов активиноподобной рецепторной киназы ( alk-4 или alk-5 ) | |
MY150059A (en) | Pyrrolo [2,3-d] pyrimidin derivatives as protein kinase b inhibitors | |
MX339899B (es) | Compuestos de triazolopiridina como inhibidores de pim cinasa. | |
MX2009004715A (es) | Compuestos heterociclicos como agentes antiinflamatorios. | |
MX2009010728A (es) | Compuestos de imidazo[1,2-a]piridina como inhibidores de la tirosina-cinasa repectora. | |
IN2012DN02577A (fr) | ||
TW200637863A (en) | Organic compounds | |
MX2013010898A (es) | Novedoso derivados de la pirimidina. | |
MX2010009646A (es) | Agentes terapeuticos antivirales. | |
MX2012008911A (es) | Sales y polimorfos de 8-fluoro-2-{4-[(metilamino)metil]fenil}-1,3, 4,5-tetrahidro-6h-acepino[5,4,3-cd]indol-6-ona. | |
IN2012DN01641A (fr) | ||
MX2012013274A (es) | Novedosos derivados de la pirimidina. | |
TW200630366A (en) | Organic compounds | |
IN2012DN01642A (fr) | ||
MX2012002327A (es) | Inhibidores de cinasa, formas de profarmaco de los mismos y su uso en terapia. | |
WO2007068473A3 (fr) | Composés organiques | |
EA201101604A1 (ru) | [1,2,4]триазоло[4,3-b]пиридазины в качестве лигандов андрогенового рецептора | |
NZ594186A (en) | Indole derivatives as anticancer agents | |
TN2013000483A1 (en) | Solid forms and salts of tetrahydro-pyrido-pyrimidine derivatives | |
CU20100147A7 (es) | Pirrolo-pirimidinas y pirrolo-piridinas | |
UA100390C2 (en) | Pyrrolo[2,3-d]pyrimidin derivatives as protein kinase b inhibitors |